{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:28:41Z","timestamp":1773242921327,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T00:00:00Z","timestamp":1125014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Recent evidence suggests the important role of matrix metalloproteinases (MMPs) in the progression of atherosclerosis and development of clinical events. We assessed the prognostic value of different plasma MMPs in patients with stable coronary artery disease (CAD).<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> A total of 165 consecutive nondiabetic patients with angiographically significant CAD (<jats:italic>n<\/jats:italic>\u00a0=\u00a0150) or normal coronary angiograms despite exercise\u2010induced myocardial ischemia (cardiac syndrome X, <jats:italic>n<\/jats:italic>\u00a0=\u00a015) and 17 normal subjects were evaluated. In each subject, plasma inflammatory markers including high sensitivity C\u2010reactive protein (hsCRP) and MMP\u20102, 3 and 9 were measured. In CAD patients, major cardiovascular events including cardiac death, nonfatal myocardial infarction, unscheduled coronary revascularization and hospitalization as a result of unstable angina were prospectively followed up for more than 6 months.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Plasma levels of MMPs were significantly higher in CAD patients than in those with cardiac syndrome X and in normal subjects (MMP\u20102: 914\u00b776\u00a0\u00b1\u00a013\u00b720 vs. 830\u00b779\u00a0\u00b1 31\u00b795 vs. 783\u00b708\u00a0\u00b1\u00a028\u00b740\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup>, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7002; MMP\u20103: 129\u00b759\u00a0\u00b1\u00a04\u00b721 vs. 116\u00b786\u00a0\u00b1\u00a08\u00b709 vs. 91\u00b771\u00a0\u00b1\u00a09\u00b755\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup>, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7011; MMP\u20109: 31\u00b742\u00a0\u00b1\u00a02\u00b784 vs. 11\u00b740\u00a0\u00b1\u00a05\u00b749 vs. 6\u00b771\u00a0\u00b1 2\u00b789\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup>, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7006). In CAD patients, there were 48 major cardiovascular events during a mean follow\u2010up period of 17\u00b774 \u00b1 0\u00b785\u00a0months. The numbers of diseased vessels (HR\u00a0=\u00a02\u00b719, 95% CI 1\u00b720\u20131\u00b702, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7011), plasma hsCRP (HR\u00a0=\u00a02\u00b721, 95% CI 1\u00b718\u20134\u00b711, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7013) and MMP\u20103 level (HR\u00a0=\u00a02\u00b746, 95% CI\u00a0=\u00a01\u00b715\u20135\u00b728, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7021) were associated with the development of cardiovascular events. However, only the plasma MMP\u20103 level was an independent predictor of the adverse events in CAD patients (HR\u00a0=\u00a02\u00b747, 95% CI 1\u00b710\u20135\u00b754, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7028).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Plasma MMP levels were increased in CAD patients. Plasma MMP\u20103 level, rather than hsCRP, was an independent prognostic marker for future cardiovascular events, suggesting its potential role in risk stratification and clinical management of stable CAD.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2005.01548.x","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T10:21:59Z","timestamp":1125051719000},"page":"537-545","source":"Crossref","is-referenced-by-count":50,"title":["Plasma matrix metalloproteinase\u20103 level is an independent prognostic factor in stable coronary artery disease"],"prefix":"10.1111","volume":"35","author":[{"given":"T. C.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. B.","family":"Leu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. T.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,26]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00615-3"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.24.2382"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.77.5.863"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117619"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1096\/fasebj.5.8.1850705","article-title":"Matrix metalloproteinases and their inhibitors in connective tissue remodeling","volume":"5","author":"Wossner JF","year":"1991","journal-title":"FASEB J"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9525(90)90126-Q"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00371-8"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02346-9"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00482-0"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/2002\/418383"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000058700.41738.12"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/39.4.561"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07591-5"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02236-1"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc3701.095949"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.18.2149"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365510260296483"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00250-2"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2001.060"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00107-7"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119076"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.15.9749"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.6.1393"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00368-6"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01907-1"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2005.01548.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2005.01548.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:49:36Z","timestamp":1697215776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2005.01548.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,26]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1365-2362.2005.01548.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01548.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,26]]}}}